Archive: 05/02/2013

FDA approves Procysbi for nephropathic cystinosis

(HealthDay)—Procysbi (cysteamine bitartrate) delayed-release capsules have been approved by the U.S. Food and Drug Administration to treat nephropathic cystinosis in children (6 years and up) and adults. ...

May 02, 2013
popularity not rated yet | comments 0

DCIS Score quantifies risk of ipsilateral breast event

The ductal carcinoma in situ (DCIS) Score quantifies the risk of ipsilateral breast event (IBE) and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to ...

May 02, 2013
popularity not rated yet | comments 0